$4.38
-0.29-6.21%
At close: May 29, 5:00 PM EST
$4.86
0.194.07%
Pre-Market: 7:00 AM EST
Atea Pharmaceuticals Inc Earnings Estimates
AVIRNASDAQ
Atea Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:AVIR
Atea Pharmaceuticals (AVIR) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $-0.56 and quarterly revenue of N/A.
In the most recent quarter (Q1), Atea Pharmaceuticals reported EPS of $-0.57, missing estimates of $-0.56 by 0.02%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Atea Pharmaceuticals has missed EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, Atea Pharmaceuticals has averaged an EPS surprise of 0.12% and a revenue surprise of 0.00%.
Earnings Date
Aug 6
EPS Estimate
$-0.560
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Atea Pharmaceuticals Earnings History
Analyze the earnings history of Atea Pharmaceuticals using advanced sorting and filters.
Loading calendar...
Atea Pharmaceuticals (AVIR) Earnings Per Share
The chart below shows Atea Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Atea Pharmaceuticals (AVIR) Revenue
The chart below shows Atea Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Atea Pharmaceuticals (NASDAQ:AVIR) reporting earnings?
Atea Pharmaceuticals (AVIR) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on May 12, 2026 for Q1.
What were the latest earnings per share (EPS) for Atea Pharmaceuticals (NASDAQ:AVIR)?
The Actual EPS was $-0.57, which missed the estimate of $-0.56.
What were Atea Pharmaceuticals’s (NASDAQ:AVIR) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
